Morphic (MORF) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free MORF Stock Alerts $30.37 -0.45 (-1.46%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 8:00 AM | globenewswire.comMorphic to Participate in Jefferies Global Healthcare ConferenceMay 26, 2024 | americanbankingnews.comMorphic (NASDAQ:MORF) Trading Up 6.8%May 24, 2024 | marketbeat.comMorphic (NASDAQ:MORF) Trading 6.8% Higher Morphic (NASDAQ:MORF) Shares Up 6.8%May 24, 2024 | marketbeat.comMorphic Holding, Inc. (NASDAQ:MORF) Position Boosted by BNP Paribas Financial MarketsBNP Paribas Financial Markets increased its holdings in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 98.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,351 shares of the company's stockMay 21, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 26,038 Shares of Morphic Holding, Inc. (NASDAQ:MORF)Assenagon Asset Management S.A. trimmed its stake in shares of Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 26.7% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 71,384 shares of the company's stock after selling 26,038 shares during theMay 21, 2024 | finance.yahoo.comMorphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking CellsMay 16, 2024 | marketbeat.comMorphic (NASDAQ:MORF) Sees Strong Trading VolumeMorphic (NASDAQ:MORF) Sees Large Volume IncreaseMay 15, 2024 | seekingalpha.comMORF Morphic Holding, Inc.May 9, 2024 | finance.yahoo.comMorphic to Participate in RBC Capital Markets Global Healthcare ConferenceApril 26, 2024 | markets.businessinsider.comMorphic Holding’s Financial Strength and Promising MORF-057 Clinical Trials Spur Buy RatingApril 26, 2024 | markets.businessinsider.comMorphic Holding’s Buy Rating Affirmed: Promising Trials and Strong Financial OutlookApril 26, 2024 | marketbeat.comJennison Associates LLC Buys Shares of 616,950 Morphic Holding, Inc. (NASDAQ:MORF)Jennison Associates LLC bought a new stake in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 616,950 shares of the company's stock, valued at approximately $17,818,000. Jennison Associates LLC owned approxiApril 25, 2024 | finance.yahoo.comMorphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed ReviewApril 25, 2024 | globenewswire.comMorphic Announces Corporate Highlights and Financial Results for the First Quarter 2024April 21, 2024 | marketbeat.comFederated Hermes Inc. Has $28.88 Million Stake in Morphic Holding, Inc. (NASDAQ:MORF)Federated Hermes Inc. increased its stake in shares of Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 13.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,000,000 shares of the company's stock after purcApril 16, 2024 | marketbeat.comMorphic (NASDAQ:MORF) Trading Down 4.4%Morphic (NASDAQ:MORF) Shares Down 4.4%April 9, 2024 | marketbeat.comVanguard Group Inc. Raises Holdings in Morphic Holding, Inc. (NASDAQ:MORF)Vanguard Group Inc. boosted its position in shares of Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 10.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,107,410 shares of the company's stock after buyApril 2, 2024 | prnewswire.comAdemi LLP Investigates Claims of Securities Fraud against Morphic Holding, Inc.April 1, 2024 | marketbeat.comMorphic (NASDAQ:MORF) Stock Price Down 5.9%Morphic (NASDAQ:MORF) Shares Down 5.9%March 26, 2024 | businesswire.comMorphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 22, 2024 | insidermonkey.comBillionaire Steve Cohen and Insiders are Buying These 5 StocksMarch 19, 2024 | finanznachrichten.deMorphic Therapeutic: Morphic Appoints Dr. Simon Cooper as Chief Medical OfficerMarch 19, 2024 | markets.businessinsider.comMorphic Appoints Simon Cooper As Chief Medical OfficerMarch 19, 2024 | globenewswire.comMorphic Appoints Dr. Simon Cooper as Chief Medical OfficerMarch 19, 2024 | marketbeat.comWellington Management Group LLP Increases Position in Morphic Holding, Inc. (NASDAQ:MORF)Wellington Management Group LLP boosted its holdings in shares of Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 48.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,421,820 shares ofMarch 17, 2024 | finance.yahoo.comMORF Jul 2024 17.500 putMarch 16, 2024 | finance.yahoo.comMORF Apr 2024 50.000 callMarch 16, 2024 | finance.yahoo.comMORF Apr 2024 20.000 putMarch 16, 2024 | finance.yahoo.comMORF Jul 2024 40.000 callMarch 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Morphic Holding (MORF)March 8, 2024 | markets.businessinsider.comMorphic Holding: Strong Financials and Promising Clinical Trials Reinforce Buy RatingMarch 8, 2024 | marketbeat.comMorphic Holding, Inc. (NASDAQ:MORF) Shares Acquired by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC increased its position in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 272.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 108,500 shares of the company'sMarch 7, 2024 | marketbeat.comSeven Eight Capital LP Makes New Investment in Morphic Holding, Inc. (NASDAQ:MORF)Seven Eight Capital LP bought a new position in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 51,022 shares of the company's stock, valued at approximately $1,169,000March 5, 2024 | globenewswire.comMorphic to Participate in March Investor ConferencesMarch 3, 2024 | ca.finance.yahoo.comMORF Jul 2024 30.000 callMarch 3, 2024 | marketbeat.comMorphic Holding, Inc. (NASDAQ:MORF) Holdings Lifted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its holdings in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 14.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 304,276 shares oMarch 1, 2024 | marketbeat.comMPM Bioimpact LLC Takes Position in Morphic Holding, Inc. (NASDAQ:MORF)MPM Bioimpact LLC bought a new stake in shares of Morphic Holding, Inc. (NASDAQ:MORF - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 200,000 shares of the company's stock, valued at approximately $4,582,000. MorFebruary 26, 2024 | markets.businessinsider.comMorphic Holding’s Strong Clinical Progress and Financial Stability Support Buy RatingFebruary 26, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)February 25, 2024 | marketbeat.comMorphic Holding, Inc. (NASDAQ:MORF) Stock Holdings Decreased by Fmr LLCFmr LLC reduced its stake in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 5.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,522,060 shares of the company's stock after selling 351,754 shares duringFebruary 23, 2024 | markets.businessinsider.comMorphic Holding’s Buy Rating Affirmed on Strong Clinical and Financial ProspectsFebruary 22, 2024 | finanznachrichten.deMorphic Therapeutic: Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023February 22, 2024 | benzinga.comRecap: Morphic Holding Q4 EarningsFebruary 22, 2024 | finance.yahoo.comMorphic Announces Corporate Highlights and Financial Results for the Full Year 2023February 22, 2024 | globenewswire.comMorphic Announces Corporate Highlights and Financial Results for the Full Year 2023February 18, 2024 | marketbeat.comSilverarc Capital Management LLC Has $13.54 Million Stock Position in Morphic Holding, Inc. (NASDAQ:MORF)Silverarc Capital Management LLC boosted its stake in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) by 134.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 590,829 shares of the company's stock after purchasing anFebruary 17, 2024 | marketbeat.comSkandinaviska Enskilda Banken AB publ Invests $321,000 in Morphic Holding, Inc. (NASDAQ:MORF)Skandinaviska Enskilda Banken AB publ bought a new stake in Morphic Holding, Inc. (NASDAQ:MORF - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 13,984 shares of the company's stock, valued at aFebruary 14, 2024 | msn.comNew Strong Buy Stocks for February 14thFebruary 8, 2024 | finance.yahoo.comWall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 57.22%: Read This Before Placing a BetFebruary 8, 2024 | marketbeat.comMorphic Holding, Inc. (NASDAQ:MORF) Forecasted to Post FY2023 Earnings of ($3.30) Per ShareMorphic Holding, Inc. (NASDAQ:MORF - Free Report) - Investment analysts at Leerink Partnrs upped their FY2023 earnings per share estimates for shares of Morphic in a report released on Monday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($3. Get Morphic News Delivered to You Automatically Sign up to receive the latest news and ratings for MORF and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market… Click here for the details MORF Media Mentions By Week MORF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MORF News Sentiment▼0.620.75▲Average Medical News Sentiment MORF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MORF Articles This Week▼32▲MORF Articles Average Week Get Morphic News Delivered to You Automatically Sign up to receive the latest news and ratings for MORF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Syndax Pharmaceuticals News Today RedHill Biopharma News Today Ionis Pharmaceuticals News Today Organon & Co. News Today BridgeBio Pharma News Today Grifols News Today Cytokinetics News Today Apellis Pharmaceuticals News Today Madrigal Pharmaceuticals News Today Alpine Immune Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MORF) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morphic Holding, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
